This inventor holds 1 USPTO granted patent. Top assignee: Institut Pasteur. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: The Innovations of Francedillaoise Brun-Vezinet in HIV Research
Introduction
Francedillaoise Brun-Vezinet is a prominent inventor based in Paris, France, known for his significant contributions to the research of human immunodeficiency virus type 2 (HIV-2). His innovative methods have paved the way for advancements in understanding this retrovirus and its antigens, benefiting the scientific community and public health.
Latest Patents
Brun-Vezinet holds a patent for "Methods for the preparation of human immunodeficiency virus type 2." This patent outlines techniques for producing the newly discovered HIV-2 retrovirus and its antigens. Notably, the antigen compositions include a lysate of an HIV-2 retrovirus, a protein of an HIV-2 retrovirus, or a glycoprotein of an HIV-2 retrovirus. Specifically, these compositions can feature p12, p16, p26, gp32, gp42, and gp140, marking an essential advancement in the field of retrovirology.
Career Highlights
Brun-Vezinet’s career is marked by his role at Institut Pasteur, where he has conducted groundbreaking research on HIV-2. His innovative work not only reflects his expertise but positions him as a key figure in the ongoing battle against HIV/AIDS. The institute has long been at the forefront of microbiology and infectious disease research, making Brun-Vezinet's contributions all the more significant.
Collaborations
Throughout his career, Brun-Vezinet has collaborated with notable scientists, including Luc Montagnier, a Nobel Laureate recognized for his discovery of HIV, and Solange Chamaret. These collaborations have enriched his research and further advanced the understanding of HIV-2.
Conclusion
Francedillaoise Brun-Vezinet's contributions to HIV research through his innovative patent and teamwork at Institut Pasteur illustrate his pivotal role in the field. His work not only enhances scientific understanding of HIV-2 but also offers potential pathways for future therapeutic developments. The innovations brought forth by Brun-Vezinet will undoubtedly continue to impact the fight against HIV and contribute to public health advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile